<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>22(1)</volume><submitter>Wei QC</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>In recent years, several studies have demonstrated that stress hyperglycemia is significantly associated with poor prognosis in patients diagnosed with acute coronary syndrome (ACS). In the present study, we aimed to investigate the potential associations between various markers of stress hyperglycemia, such as admission blood glucose (ABG), fasting blood sugar (FBS), and stress hyperglycemia ratio (SHR) with different definitions, and the occurrence of adverse cardiovascular events in patients diagnosed with ST-elevation myocardial infarction (STEMI) who have undergone percutaneous coronary intervention (PCI).&lt;h4>Methods&lt;/h4>Our study enrolled a total of 1099 patients diagnosed with STEMI who underwent PCI from 2016 to 2021. The primary outcomes of this study were in-ho</pubmed_abstract><journal>Cardiovascular diabetology</journal><pagination>85</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10100063</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Association of stress hyperglycemia with clinical outcomes in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention: a cohort study.</pubmed_title><pmcid>PMC10100063</pmcid><pubmed_authors>Ren KD</pubmed_authors><pubmed_authors>He F</pubmed_authors><pubmed_authors>Jiang J</pubmed_authors><pubmed_authors>Wei QC</pubmed_authors><pubmed_authors>Gao QY</pubmed_authors><pubmed_authors>Shi JT</pubmed_authors><pubmed_authors>Chen YW</pubmed_authors><pubmed_authors>Liu YB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association of stress hyperglycemia with clinical outcomes in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention: a cohort study.</name><description>&lt;h4>Background&lt;/h4>In recent years, several studies have demonstrated that stress hyperglycemia is significantly associated with poor prognosis in patients diagnosed with acute coronary syndrome (ACS). In the present study, we aimed to investigate the potential associations between various markers of stress hyperglycemia, such as admission blood glucose (ABG), fasting blood sugar (FBS), and stress hyperglycemia ratio (SHR) with different definitions, and the occurrence of adverse cardiovascular events in patients diagnosed with ST-elevation myocardial infarction (STEMI) who have undergone percutaneous coronary intervention (PCI).&lt;h4>Methods&lt;/h4>Our study enrolled a total of 1099 patients diagnosed with STEMI who underwent PCI from 2016 to 2021. The primary outcomes of this study were in-ho</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Apr</publication><modification>2025-04-22T10:03:53.43Z</modification><creation>2025-02-18T23:40:29.897Z</creation></dates><accession>S-EPMC10100063</accession><cross_references><pubmed>37046267</pubmed><doi>10.1186/s12933-023-01812-9</doi></cross_references></HashMap>